Will Barone, PsyD who's worked in research in clinical settings with therapies involving MDMA, psilocybin, and ketamine, says "Ketamine is the primary substance I would feel comfortable working with for a bipolar client.” He explains that ketamine doesn't work nearly as much on serotonin as other entheogens, that instead, its primary action is on the glutamate and NMDA receptors. Read the full article: psychedelicstoday bit.ly/3G9AJ1I #bipolardisorder #ivketamine #psychedelicmedicine